X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ

$2.78

$-0.01

(-0.32%)

Pre-Market

X4 Pharmaceuticals, Inc. (XFOR) Live Price Chart

Last updated: ⁦2026-10-20 12:02:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

X4 Pharmaceuticals, Inc. (XFOR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.78, with a market capitalization of $256.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.43 to $4.83. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$256.79M
Open	$2.79
Day's High	$717.90
Day's Low	$1.35
Previous Close	$2.75
Volume	28.00
Average Volume	844.85K
P/E Ratio	--
52-Week High	$4.83
52-Week Low	$2.43
Dividend Yield	--
Earnings Date	--

X4 Pharmaceuticals, Inc. (XFOR) Pre-Market Stock Price

X4 Pharmaceuticals, Inc. (XFOR) is trading at $2.78 in pre-market trading as of 2026-10-20 11:17:00, up 0.95% ($0.03) from the previous close of $2.75

Pre-market trading shows how investors are pricing XFOR before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

X4 Pharmaceuticals, Inc. (XFOR) 7-Day Stock Price Change

Over the past seven days, X4 Pharmaceuticals, Inc. (XFOR) moved from $2.91 to $2.78, representing a decline of 4.60% ($0.13).

The stock traded between $2.43 and $2.97 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 601.67 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

XFOR 52-Week Price Position

Position in Range: 14.4%

52W Low$2.43

52W High$4.83

XFOR is currently trading at $2.78, placing it 14.4% of the way from its 52-week low of $2.43 to its 52-week high of $4.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is X4 Pharmaceuticals, Inc. (XFOR)?

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Pharmaceuticals, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	45
Exchange	NASDAQ
Company Website	https://www.x4pharma.com

How to Buy X4 Pharmaceuticals, Inc. (XFOR) Stock on MEXC

Eligible investors can buy real shares of X4 Pharmaceuticals, Inc. (XFOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XFOR and Place Your Order

Open the RealStocks trading page and search for XFOR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is X4 Pharmaceuticals, Inc. (XFOR) stock price today?

X4 Pharmaceuticals, Inc. (XFOR) is currently trading at $ 2.78, up 0.95% ($0.03) from the previous close of $ 2.75. Intraday prices update in real time during regular trading hours.

2.Is XFOR stock going up or down today?

As of 2026-10-20 11:17:00, XFOR is trading at $ 2.78, up 0.95% ($0.03) from its previous close of $ 2.75. The stock has traded between $ 1.35 and $ 717.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is XFOR pre-market price?

As of 2026-10-20 11:17:00, XFOR is trading at $ 2.78 in pre-market trading, up 0.95% ($0.03) from the previous close of $ 2.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XFOR after-hours price?

As of 2026-10-20 11:17:00, XFOR is trading at $ 2.79 in after-hours trading, up 1.27% ($0.04) from the regular-session close of $ 2.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XFOR stock trading now?

XFOR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XFOR sit relative to its 52-week high and low?

Over the past 52 weeks, XFOR has traded between a low of $ 2.43 and a high of $ 4.83. At $ 2.78, the stock is positioned 14.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is X4 Pharmaceuticals, Inc. in?

X4 Pharmaceuticals, Inc. (XFOR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is X4 Pharmaceuticals, Inc.'s market capitalization and where is it listed?

X4 Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 256.79M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XFOR valued in terms of P/E ratio and EPS?

XFOR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.91. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does X4 Pharmaceuticals, Inc. pay a dividend?

X4 Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.